Common gout drug tested as lifeline for advanced liver cancer patients
NCT ID NCT04264260
Summary
This study tested whether colchicine, a medication commonly used for gout, could help control advanced liver cancer in patients who could not receive treatments aimed at curing their disease. The trial involved 42 participants with advanced liver tumors and compared their outcomes to similar patients from medical records. The main goal was to see if adding colchicine to their care could help them live longer, while also monitoring for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA STAGE IIIB are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Medical University Hospital
Kaohsiung City, 807, Taiwan
Conditions
Explore the condition pages connected to this study.